2542.TW - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)

0.29x

Defensive

Volatility (5Y p.a.)

25.3% p.a.

5-Year Horizon

Max Drawdown (5Y)

-40.6%

5-Year Horizon

Sharpe Ratio

0.06

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y)

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+0.3%
3 Years	29.3%	-40.6%	0.05	+4.6%
5 Years	25.3%	-40.6%	0.06	+4.1%
10 Years	22.6%	-40.6%	-0.01	+2.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 275%.

Strong cyclicality: The business model is sensitive to economic downturns.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (29.3%) is noticeably higher than the 5Y average (25.3%).

Historical Stress Test: Maximum peak-to-trough drawdown of -40.6% in the extended horizon.